Bioxyne Limited (BXN.AX) Comparison with companies in other sectors?

Bioxyne Limited has a share price of 2.16B. You can analyze Bioxyne Limited (BXN.AX) competitors across different market sectors through stock heatmaps.

What are BXN.AX's NET and operating margins?

Bioxyne Limited (BXN.AX) operating margin is around 0.22, and net profit margin is approximately 0.13 as of the latest reports.

In what way does BXN.AX's earnings per share (EPS) trend reflect its financial momentum?

Bioxyne Limited (BXN.AX) EPS is -0.01 (If EPS value is positive, then “signals consistent profit growth” if Negative then “signals consistent loss”). This metric is also critical in assessing valuation metrics like the P/E ratio for Bioxyne Limited is -4.90, and the company’s ability to reinvest or distribute profits.

What does a high ROE mean for Bioxyne Limited?

A high ROE suggests efficient use of shareholder equity to generate profit. It often signals strong management and profitability.

How do I know if AAPL is overvalued or undervalued?

Check valuation ratios for Bioxyne Limited like P/E which is 44.90, P/B which is 13.95, and PEG which is 0.39. Compare them with sector averages to evaluate if the stock is priced fairly.

Bioxyne Limited

BXN.AX•ASX

Consumer Defensive

Packaged Foods

A$0.05

A$0.002(4.26%)

Fundamental Analysis of Bioxyne Limited (BXN.AX)

Comprehensive financial metrics and ratios analysis

EPS (TTM)

$-0.01

P/E Ratio

-4.90

ROE

0.41%

Net Margin

0.13%

Key Financial Metrices

Valuation Metrics

4 metrics

Market CapTotal market value of outstanding shares

$106.08M

Shares OutstandingTotal number of shares issued

$2.16B

Book Value/ShareNet worth per share

$0.003

Revenue/ShareAnnual revenue per share

$0.008

Profitability Metrics

6 metrics

EPS (TTM)Earnings per share trailing twelve months

$-0.01

Net MarginNet income as percentage of revenue

13.01%

Operating MarginOperating income as percentage of revenue

21.74%

ROEReturn on shareholders' equity

41.41%

ROAReturn on total assets

14.99%

ROCEReturn on capital employed

45.75%

Cash Flow Metrics

3 metrics

Free Cash Flow/ShareCash generated per share after capex

$0.00

Cash/ShareCash and equivalents per share

$0.001

FCF YieldFree cash flow as percentage of market cap

0.10%

Dividend Metrics

2 metrics

Dividend/ShareAnnual dividend payment per share

Dividend YieldAnnual dividend as percentage of stock price

Financial Ratios Analysis data is not available for BXN.AXFinancial Ratios Analysis details for BXN.AX are currently unavailable. We're actively monitoring for updates and will publish them as soon as they’re released. Please check back again shortly.

Sector Benchmarking data is not available for BXN.AXSector Benchmarking details for BXN.AX are currently unavailable. We're actively monitoring for updates and will publish them as soon as they’re released. Please check back again shortly.

Understanding Fundamental Analysis for Bioxyne Limited Investment Decisions

What is Fundamental Analysis?

Fundamental analysis is a method used to assess the intrinsic value of Bioxyne Limited. Using financial reports, management structure, competitive position, and market environment, investors can determine whether the stock is undervalued or overvalued. This analysis helps investors like you make more informed investment decisions, taking into account Bioxyne Limited's unique business strengths and challenges.

Key Financial Metrics for Bioxyne Limited

For Bioxyne Limited, essential financial indicators include EPS -0.01, PE -4.90, and ROE 0.41. These key ratios reveal insights into Bioxyne Limited's profitability, valuation, and operational health. Understanding these metrics enables you to compare Bioxyne Limited with its industry peers and decide whether it presents a viable investment opportunity.

Profitability and Operational Efficiency of Bioxyne Limited

Metrics like Net Margin 13.01% and ROA 14.99% shed light on how well Bioxyne Limited is generating profits. A high profitability ratio often indicates strong management and a solid business model, which are essential for long-term growth. These metrics are crucial in assessing whether Bioxyne Limited can sustain its operations and continue growing in the future.

Valuation and Market Position of Bioxyne Limited

Using ratios such as P/B Ratio 13.95 and PEG Ratio 0.39, investors can assess whether Bioxyne Limited is appropriately valued based on its financials and growth potential. These figures, combined with Bioxyne Limited's market capitalization, give insight into its competitive positioning and investor expectations, helping you make informed decisions on pricing and value.

Financial Health and Risk Assessment for Bioxyne Limited

Financial health indicators, such as Debt/Equity Ratio 0.24 and Cash Flow $0.00, provide a snapshot of Bioxyne Limited's ability to meet financial obligations and handle economic setbacks. A company with a strong balance sheet and solid cash flow, like Bioxyne Limited, is more likely to weather financial storms, making it a safer investment.

Long-Term Investment Strategy for Bioxyne Limited

Investing in Bioxyne Limited based on fundamental analysis emphasizes long-term business growth rather than short-term market trends. Investors looking at Bioxyne Limited focus on its solid financial performance, industry standing, and competitive advantages, all of which suggest sustainable growth and the potential for steady returns over time.

Fundamental Analysis FAQ

;